Localized fibroglandular tissue as a predictor of future tumor location within the breast

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 8, 2011, Pages 1718-1725

  Pinto Pereira, Snehal M ^a   McCormack, Valerie A ^b   Hipwell, John H ^c   Record, Carol ^d   Wilkinson, Louise S ^e   Moss, Sue M ^f   Hawkes, David J ^c   Dos Santos Silva, Isabel ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d BUCKINGHAMSHIRE HEALTHCARE NHS TRUST   (United Kingdom)

^e ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^f INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALGORITHM; ARTICLE; BREAST CANCER; BREAST FIBROMA; CONTROLLED STUDY; DIGITAL MAMMOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIOLOGIST; RISK; SCREENING; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; PRECANCEROUS CONDITIONS;

EID: 79961243516     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-0423     Document Type: Article

References (28)

1. McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006;15:1159-69.
2. Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007;356:227-36. (Pubitemid 46143226)
3. Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, et al. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 1995;87:1622-9.
4. Vachon CM, Pankratz VS, Scott CG, Maloney SD, Ghosh K, Brandt KR, et al. Longitudinal trends in mammographic percent density and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2007;16:921-8. (Pubitemid 46910093)
5. Kerlikowske K, Ichikawa L, Miglioretti DL, Buist DS, Vacek PM, Smith-Bindman R, et al. Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst 2007;99:386-95. (Pubitemid 47073482)
6. van Gils CH, Hendriks JH, Holland R, Karssemeijer N, Otten JD, Straatman H, et al. Changes in mammographic breast density and concomitant changes in breast cancer risk. Eur J Cancer Prev 1999;8: 509-15. (Pubitemid 30019690)
7. Ursin G, Hovanessian-Larsen L, Parisky YR, Pike MC, Wu AH. Greatly increased occurrence of breast cancers in areas of mammographically dense tissue. Breast Cancer Res 2005;7:R605-8.
8. Vachon CM, Brandt KR, Ghosh K, Scott CG, Maloney SD, Carston MJ, et al. Mammographic breast density as a general marker of breast cancer risk. Cancer Epidemiol Biomarkers Prev 2007;16:43-9. (Pubitemid 46174262)
9. Pinto Pereira SM, McCormack VA, Moss SM, dos Santos Silva I. The spatial distribution of radiodense breast tissue: a longitudinal study. Breast Cancer Res 2009;11:R33.
10. Pinto Pereira SM, Hipwell JH, McCormack VA, Tanner C, Moss SM, Wilkinson LS, et al. Automated registration of diagnostic to prediagnostic x-ray mammograms: evaluation and comparison to radiologists'accuracy. Med Phys 2010;37:4530-9.
11. Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomized controlled trial. Lancet 2006;368:2053-60. (Pubitemid 44855105)
12. Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ. The quantitative analysis of mammographic densities. Phys Med Biol 1994;39:1629-38. (Pubitemid 24306719)
13. Boyd NF, Martin LJ, Bronskill M, Yaffe MJ, Duric N, Minkin S. Breast tissue composition and susceptibility to breast cancer. J Natl Cancer Inst 2010;102:1224-37.
14. Digital Breast Tomosynthesis Working Party. Digital breast tomosynthesis. UK National Health Service Breast Screening Programme. Publication No 69. NHS Cancer Screening Programmes 2010. ISBN 978-1-84463-071-4. Available from: (http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp69.html).
15. Gill JK, Maskarinec G, Pagano I, Kolonel LN. The association of mammographic density with ductal carcinoma in situ of the breast: the Multiethnic Cohort. Breast Cancer Res 2006;8:R30.
16. Turashvili G, McKinney S, Martin L, Gelmon KA, Watson P, Boyd N, et al. Columnar cell lesions, mammographic density and breast cancer risk. Breast Cancer Res Treat 2009;115:561-71.
17. Ghosh K, Vachon CM, Pankratz VS, Vierkant RA, Anderson SS, Brandt KR, et al. Independent association of lobular involution and mammographic breast density with breast cancer risk. J Natl Cancer Inst 2010;102:1716-23.
18. Ginsburg OM, Martin LJ, Boyd NF. Mammographic density, lobular involution, and risk of breast cancer. Br J Cancer 2008;99:1369-74.
19. Milanese TR, Hartmann LC, Sellers TA, Frost MH, Vierkant RA, Maloney SD, et al. Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst 2006;98:1600-7. (Pubitemid 44811643)
20. Amir E, Freedman OC, Seruga B, Evans DG. Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst 2010;102:680-91.
21. Chen J, Pee D, Ayyagari R, Graubard B, Schairer C, Byrne C, et al. Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst 2006;98:1215-26. (Pubitemid 44390992)
22. Santen RJ, Boyd NF, Chlebowski RT, Cummings S, Cuzick J, Dowsett M, et al. Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model. Endocr Relat Cancer 2007;14:169-87. (Pubitemid 47242621)
23. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879-86. (Pubitemid 20026073)
24. Cuzick J, Warwick J, Pinney E, Warren RM, Duffy SW. Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst 2004;96:621-8. (Pubitemid 38584986)
25. National Collaborating Centre for Primary Care. NHS National Institute for Health and Clinical Excellence (NICE). Familial breast cancer. The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care. Nice clinical guideline 41. NICE, 2006. Available from: http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp69.html.
26. Hartmann LC, Sellers TA, Schaid DJ, Frank TS, Soderberg CL, Sitta DL, et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 2001;93:1633-7. (Pubitemid 33094870)
27. Lostumbo L, Carbine NE, Wallace J. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev 2010;11: CD002748.
28. Leach MO, Boggis CR, Dixon AK, Easton DF, Eeles RA, Evans DG, et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 2005;365:1769-78. (Pubitemid 40744657)